Dispatches from FIE 2011

Oat beta glucan makes claims on European cholesterol market

By Shane Starling in Paris

- Last updated on GMT

Related tags: European union, Managing director, Corporate governance

The European Union cholesterol-lowering market has a new player after an oat beta glucan's claim was written in to European law books this month.

Ruedi Duss, the managing director of CreaNutrition, the Swiss-Swedish oat beta glucan specialist behind the claim, told NutraIngredients what it means to have won a rare article 14 disease risk factor reduction claim: After a few millions of euros of investment, it means a lot.

Related news

Show more

Related products

show more

cognitaven® boosts cognitive performance

cognitaven® boosts cognitive performance

Anklam Extrakt GmbH | 13-Jul-2020 | Clinical Study

Within the course of a randomised, double-blind, placebo-controlled study, the acute and chronic effects of green oat (Avena sativa) herb extract on cognitive...

Related suppliers

Follow us

Products

View more

Webinars